REVERAGEN BIOPHARMA, INC.

Organization

SILVER SPRING, MD, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Non-hormonal steroid modulators of NF-kB for treatment of disease
- Patent number 11,833,159
- Issue date Dec 5, 2023
- ReveraGen BioPharma, Inc.
- John M. McCall
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Non-hormonal steroid modulators of NF-κβ for treatment of disease
- Patent number 11,690,853
- Issue date Jul 4, 2023
- ReveraGen BioPharma, Inc.
- John M. McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aqueous oral pharmaceutical suspension compositions
- Patent number 11,471,471
- Issue date Oct 18, 2022
- ReveraGen BioPharma, Inc.
- John McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aqueous oral pharmaceutical suspension compositions
- Patent number 11,382,922
- Issue date Jul 12, 2022
- ReveraGen BioPharma, Inc.
- John McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-hormonal steroid modulators of NF-kB for treatment of disease
- Patent number 10,857,161
- Issue date Dec 8, 2020
- ReveraGen BioPharma, Inc.
- John M. McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-hormonal steroid modulators of NF-kappa beta for treatment of d...
- Patent number 10,799,514
- Issue date Oct 13, 2020
- ReveraGen BioPharma, Inc.
- John M. McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-hormonal steroid modulators of NF-κβ for treatment of disease
- Patent number 10,464,967
- Issue date Nov 5, 2019
- ReveraGen BioPharma, Inc.
- John M. McCall
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Non-hormonal steroid modulators of NF-kB for treatment of disease
- Patent number 10,206,933
- Issue date Feb 19, 2019
- ReveraGen BioPharma, Inc.
- John M. McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-hormonal steroid modulators of NF-κB for treatment of disease
- Patent number 10,000,525
- Issue date Jun 19, 2018
- ReveraGen BioPharma, Inc.
- John M. McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-hormonal steroid modulators of NF-κB for treatment of disease
- Patent number 9,649,320
- Issue date May 16, 2017
- ReveraGen BioPharma, Inc.
- John M. McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and agents to increase therapeutic dystrophin expression in...
- Patent number 9,637,738
- Issue date May 2, 2017
- ReveraGen BioPharma, Inc.
- Eric Hoffman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-hormonal steroid modulators of NF-κB for treatment of disease
- Patent number 9,434,758
- Issue date Sep 6, 2016
- ReveraGen BioPharma, Inc.
- John M. McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-hormonal steroid modulators of NF-κB for treatment of disease
- Patent number 9,198,921
- Issue date Dec 1, 2015
- ReveraGen BioPharma, Inc.
- John M. McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-hormonal steroid modulators of NF-kB for treatment of disease
- Patent number 8,673,887
- Issue date Mar 18, 2014
- Reveragen Biopharma, Inc
- John M. McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...
- Publication number 20240307411
- Publication date Sep 19, 2024
- Reveragen Biopharma, Inc.
- John M. McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF NF-kB-MEDIATED DISEASE
- Publication number 20240299416
- Publication date Sep 12, 2024
- Reveragen Biopharma, Inc.
- Jesse DAMSKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE
- Publication number 20240285650
- Publication date Aug 29, 2024
- Reveragen Biopharma, Inc.
- John M. MCCALL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CONGENITAL ADRENAL HYPOPLASIA
- Publication number 20240226117
- Publication date Jul 11, 2024
- Reveragen Biopharma, Inc.
- Eric Hoffman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF NF-KB-MEDIATED DISEASE
- Publication number 20240139210
- Publication date May 2, 2024
- Reveragen Biopharma, Inc.
- Jesse DAMSKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AQUEOUS ORAL PHARMACEUTICAL SUSPENSION COMPOSITIONS
- Publication number 20230027370
- Publication date Jan 26, 2023
- Reveragen Biopharma, Inc.
- John MCCALL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS OF VAMOROLONE
- Publication number 20230002439
- Publication date Jan 5, 2023
- Reveragen Biopharma, Inc.
- John MCCALL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...
- Publication number 20220324902
- Publication date Oct 13, 2022
- Reveragen Biopharma, Inc.
- John M. MCCALL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF NF-KB-MEDIATED DISEASE
- Publication number 20220184098
- Publication date Jun 16, 2022
- Reveragen Biopharma, Inc.
- Jesse DAMSKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE
- Publication number 20210052606
- Publication date Feb 25, 2021
- Reveragen Biopharma, Inc.
- John M. MCCALL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...
- Publication number 20210046089
- Publication date Feb 18, 2021
- Reveragen Biopharma, Inc.
- John M. McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AQUEOUS ORAL PHARMACEUTICAL SUSPENSION COMPOSITIONS
- Publication number 20200281942
- Publication date Sep 10, 2020
- Reveragen Biopharma, Inc.
- John MCCALL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...
- Publication number 20200148717
- Publication date May 14, 2020
- Reveragen Biopharma, Inc.
- John M. MCCALL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE
- Publication number 20190125763
- Publication date May 2, 2019
- Reveragen Biopharma, Inc.
- John M. MCCALL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE
- Publication number 20180015104
- Publication date Jan 18, 2018
- Reveragen Biopharma, Inc.
- John M. MCCALL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE
- Publication number 20170027959
- Publication date Feb 2, 2017
- Reveragen Biopharma, Inc.
- John M. McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...
- Publication number 20160375037
- Publication date Dec 29, 2016
- Reveragen Biopharma, Inc.
- John M. McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NON-HORMONAL STEROID MODULATORS OF NF-KAPPA B FOR TREATMENT OF DISEASE
- Publication number 20160060289
- Publication date Mar 3, 2016
- Reveragen Biopharma, Inc.
- John M. McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...
- Publication number 20150011519
- Publication date Jan 8, 2015
- Reveragen Biopharma, Inc.
- John M. McCall
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE
- Publication number 20140142078
- Publication date May 22, 2014
- ReveraGen Biopharma
- John M. McCall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
86386224 - REVERAGEN BIOPHARMA
- Serial number 86386224
- Registration number 4742704
- Filing date Sep 5, 2014
- Reveragen Biopharma, Inc
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
86386229 - REVERAGEN
- Serial number 86386229
- Registration number 4720198
- Filing date Sep 5, 2014
- Reveragen Biopharma, Inc
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
85466781 - REVERA GEN
- Serial number 85466781
- Filing date Nov 8, 2011
- Reveragen Biopharma, Inc
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
85466817 - REVERAGEN
- Serial number 85466817
- Filing date Nov 8, 2011
- Reveragen Biopharma, Inc
- 5 - Pharmaceutical and veterinary preparations

NIH Research Projectlast 12 months

processing...

Count: 15

Research Projects

Information Research Project
Commercialization Readiness Pilot (CRP) to maximize vamorolone inte...
- Application id 10200153
- Award notice date Sep 1, 2021
Information Research Project
Commercialization Readiness Pilot (CRP) to maximize vamorolone inte...
- Application id 10008437
- Award notice date Jun 22, 2020
Information Research Project
Pivotal trial of vamorolone in Duchenne muscular dystrophy
- Application id 9767888
- Award notice date Aug 15, 2019
Information Research Project
Establishing a Cost-effective Return of Results to Parents of Boys...
- Application id 9929267
- Award notice date Jul 19, 2019
Information Research Project
Pivotal trial of vamorolone in Duchenne muscular dystrophy
- Application id 9621067
- Award notice date Aug 21, 2018
Information Research Project
Building an evidentiary case for circulating GHBP as a biomarker fo...
- Application id 9464951
- Award notice date Jun 14, 2018
Information Research Project
Definition of pharmacodynamic biomarkers for juvenile dermatomyosit...
- Application id 9526062
- Award notice date Jun 5, 2018
Information Research Project
Establishing a biomarker framework for feasibility studies of vamor...
- Application id 9525729
- Award notice date Jun 1, 2018
Information Research Project
Phase IIa study of VBP15 for Duchenne muscular dystrophy
- Application id 9222053
- Award notice date Apr 6, 2017
Information Research Project
Effectiveness of VBP15, a dissociative steroidal analogue, on chron...
- Application id 9139720
- Award notice date Mar 31, 2016
Information Research Project
Phase IIa study of VBP15 for Duchenne muscular dystrophy
- Application id 9047701
- Award notice date Feb 10, 2016
Information Research Project
Effectiveness of VBP15, a dissociative steroidal analogue, on infla...
- Application id 8978498
- Award notice date Aug 31, 2015
Information Research Project
Effect of VBP15, a dissociative steroidal analogue, on intestinal e...
- Application id 8833074
- Award notice date Sep 22, 2014
Information Research Project
Evaluation of VBP15 a dissociative steroidal analogue on pain and i...
- Application id 8722797
- Award notice date Jul 23, 2014
Information Research Project
Anti-inflammatory and Mitotic Properties of Non-hormonal Steroids i...
- Application id 8000773
- Award notice date Sep 17, 2010

REVERAGEN BIOPHARMA, INC.

Organization

Patents Grantslast 30 patents

Non-hormonal steroid modulators of NF-kB for treatment of disease

Non-hormonal steroid modulators of NF-κβ for treatment of disease

Aqueous oral pharmaceutical suspension compositions

Aqueous oral pharmaceutical suspension compositions

Non-hormonal steroid modulators of NF-kB for treatment of disease

Non-hormonal steroid modulators of NF-kappa beta for treatment of d...

Non-hormonal steroid modulators of NF-κβ for treatment of disease

Non-hormonal steroid modulators of NF-kB for treatment of disease

Non-hormonal steroid modulators of NF-κB for treatment of disease

Non-hormonal steroid modulators of NF-κB for treatment of disease

Methods and agents to increase therapeutic dystrophin expression in...

Non-hormonal steroid modulators of NF-κB for treatment of disease

Non-hormonal steroid modulators of NF-κB for treatment of disease

Non-hormonal steroid modulators of NF-kB for treatment of disease

Patents Applicationslast 30 patents

NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...

TREATMENT OF NF-kB-MEDIATED DISEASE

NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE

TREATMENT OF CONGENITAL ADRENAL HYPOPLASIA

TREATMENT OF NF-KB-MEDIATED DISEASE

AQUEOUS ORAL PHARMACEUTICAL SUSPENSION COMPOSITIONS

CRYSTALLINE FORMS OF VAMOROLONE

NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...

TREATMENT OF NF-KB-MEDIATED DISEASE

NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE

NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...

AQUEOUS ORAL PHARMACEUTICAL SUSPENSION COMPOSITIONS

NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...

NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE

NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE

NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE

NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...

NON-HORMONAL STEROID MODULATORS OF NF-KAPPA B FOR TREATMENT OF DISEASE

NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF D...

NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE

Trademarklast 30 trademarks

86386224 - REVERAGEN BIOPHARMA

86386229 - REVERAGEN

85466781 - REVERA GEN

85466817 - REVERAGEN

NIH Research Projectlast 12 months

Research Projects

Commercialization Readiness Pilot (CRP) to maximize vamorolone inte...

Commercialization Readiness Pilot (CRP) to maximize vamorolone inte...

Pivotal trial of vamorolone in Duchenne muscular dystrophy

Establishing a Cost-effective Return of Results to Parents of Boys...

Pivotal trial of vamorolone in Duchenne muscular dystrophy

Building an evidentiary case for circulating GHBP as a biomarker fo...

Definition of pharmacodynamic biomarkers for juvenile dermatomyosit...

Establishing a biomarker framework for feasibility studies of vamor...

Phase IIa study of VBP15 for Duchenne muscular dystrophy

Effectiveness of VBP15, a dissociative steroidal analogue, on chron...

Phase IIa study of VBP15 for Duchenne muscular dystrophy

Effectiveness of VBP15, a dissociative steroidal analogue, on infla...

Effect of VBP15, a dissociative steroidal analogue, on intestinal e...

Evaluation of VBP15 a dissociative steroidal analogue on pain and i...

Anti-inflammatory and Mitotic Properties of Non-hormonal Steroids i...